Avid Bioservices Inc.

NASDAQ: CDMO · Real-Time Price · USD
12.49
0.00 (0.00%)
At close: Feb 04, 2025, 3:59 PM

Avid Bioservices Income Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
Revenue
139.91M 149.27M 119.6M 95.87M
Cost of Revenue
132.59M 117.79M 82.95M 66.56M
Gross Profit
7.32M 31.48M 36.65M 29.31M
Operating Income
-18.68M -2.61M 10.86M 8.92M
Interest Income
n/a n/a n/a 133K
Pretax Income
-26.93M 2M 12.66M 11.21M
Net Income
-140.75M 560K 127.67M 11.21M
Selling & General & Admin
26M 27.88M 21.23M 17.06M
Research & Development
n/a n/a n/a n/a
Other Expenses
n/a n/a -81K 133K
Operating Expenses
26M 27.88M 21.23M 17.06M
Interest Expense
4.34M 3.01M 2.68M 1.16M
Selling & Marketing Expenses
800K 700K 600K 300K
Cost & Expenses
158.59M 145.66M 104.17M 83.63M
Income Tax Expense
113.83M 1.44M -115.01M -2.29M
Shares Outstanding (Basic)
63.2M 62.27M 61.48M 58.22M
Shares Outstanding (Diluted)
63.2M 63.78M 70.47M 59.43M
EPS (Basic)
-2.23 0.01 2.08 0.06
EPS (Diluted)
-2.23 0.01 1.81 0.06
EBITDA
-11.48M 10.91M 19.9M 15.7M
EBIT
-22.59M 3.7M 15.42M 12.24M
Depreciation & Amortization
11.11M 7.21M 4.48M 3.45M